Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials. (October 2020) - Abel, M.K.; Diaz, I.; Levine, J.; Pate, L.; Viggiano, E.; Melisko, M.; Mukhtar, R.